Award recordCONTRACT

UNITED THERAPEUTICS CORP

PIID 36C26124N0646· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2024· $191,017 net obligations· UEI KK5FBFA43JS7· MD

Description

DE-OBLIGATION OF FUNDS AND CHANGE IN QUANTITY FOR TYVASO

Base award description: TYVASO

First action · last action
2024-05-09 · 2025-01-24
Transactions
2
First transaction's obligation
$264,485
Base + all options value (sum of deltas)
$191,017
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0104
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$264,485$0Base award · 2024-05-09 · this action $264,485 · running total $264,485Modification P00001 · 2025-01-24 · this action -$73,468 · running total $191,017
  • Base2024-05-09+$264,485= $264,485
  • Mod P000012025-01-24-$73,468= $191,017
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2024-05-09+$264,485$264,485TYVASO
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-01-24−$73,468$191,017DE-OBLIGATION OF FUNDS AND CHANGE IN QUANTITY FOR TYVASO

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI KK5FBFA43JS7)

AwardOffice · PSC / listingNet obligationsFY
36C24526N0777245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$33,158FY2026
36C24526N0755245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0754245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$15,746FY2026
36C24526N0723245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0722245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026
36C24526N0707245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$17,352FY2026

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26124N0646_3600_36F79720D0104_3600 · retrieved 2026-09-26.